Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

CXCR4 Upregulation Is a Biomarker Of Sensitivity To Targeted Inhibition Of B-Cell Receptor Signaling In Diffuse Large B-Cell Lymphoma

Linfeng Chen, PhD, Yansheng Hao, MD, PhD, Jing Ouyang, PhD, Bjoern Chapuy, MD, PhD, Donna S. Neuberg, ScD, Thomas M Habermann, MD, Przemyslaw Juszczynski, MD, PhD, Scott J Rodig, MD, PhD, Stefano Monti, PhD, Margaret A Shipp, MD

Blood (2013) 122 (21): 631.

https://doi.org/10.1182/blood.V122.21.631.631

Published: 2013

Journal Articles

Galectin-1 Serum Levels Reflect Tumor Burden and Adverse Clinical Features in Hodgkin Lymphoma

Jing Ouyang, PhD, Annette Plütschow, PhD, Elke Pogge, PhD, Sabine Ponader, PhD, Gabriel Rabinovich, PhD, Donna S. Neuberg, ScD, Andreas Engert, MD, Margaret A. Shipp, MD

Blood (2012) 120 (21): 51.

https://doi.org/10.1182/blood.V120.21.51.51

Published: 2012

Journal Articles

Expression and Targeted Inhibition of the Immunoregulatory Carbohydrate-Binding Lectin, Galectin 1, in EBV-Driven Post-Transplant Lymphoproliferative Disorders.

Jing Ouyang, PhD, Przemyslaw Juszczynski, MD, PhD, Evan O'Donnell, Myriam Armant, PhD, Scott J. Rodig, MD, PhD, Kunihiko Takeyama, MD, PhD, Stefano Monti, PhD, Gabriel Rabinovich, PhD, Jeffery Lorne Kutok, MD, PhD, Jerome Ritz, MD, Margaret A. Shipp, MD

Blood (2009) 114 (22): 96.

https://doi.org/10.1182/blood.V114.22.96.96

Published: 2009

Journal Articles

Selective Expression of the Immunoregulatory Lectin, Galectin-1, in Precursor B Cell Acute Lymphoblastic Leukemias (ALLs) with MLL Rearrangements

Przemyslaw Juszczynski, MD, PhD, Scott J. Rodig, MD, PhD, Kunihiko Takeyama, MD, PhD, Jing Ouyang, PhD, Jorg Faber, MD, PhD, Scott Armstrong, MD, PhD, Jeffery L. Kutok, MD, PhD, Margaret A. Shipp, MD

Blood (2008) 112 (11): 2539.

https://doi.org/10.1182/blood.V112.11.2539.2539

Published: 2008

Journal Articles

Hodgkin’s Lymphoma Reed Sternberg Cells over Express the T-Cell Inhibitory Carbohydrate-Binding Lectin, Galectin 1: Role of AP-1 and Likely Mechanism of Tumor Immune Escape.

Przemyslaw Juszczynski, MD, PhD, Jing Ouyang, PhD, Jeffery L. Kutok, MD, PhD, Stefano Monti, PhD, Wen Chen, MD, Paola Dal Cin, PhD, Jeremy S. Abramson, MD, Kunihiko Takeyama, MD, PhD, Todd R. Golub, MD, Jon C. Aster, MD, PhD, Gabriel A. Rabinovich, PhD, Margaret A. Shipp, MD

Blood (2006) 108 (11): 469.

https://doi.org/10.1182/blood.V108.11.469.469

Published: 2006

NARROW

CXCR4 Upregulation Is a Biomarker Of Sensitivity To Targeted Inhibition Of B-Cell Receptor Signaling In Diffuse Large B-Cell Lymphoma

Galectin-1 Serum Levels Reflect Tumor Burden and Adverse Clinical Features in Hodgkin Lymphoma

Expression and Targeted Inhibition of the Immunoregulatory Carbohydrate-Binding Lectin, Galectin 1, in EBV-Driven Post-Transplant Lymphoproliferative Disorders.

Selective Expression of the Immunoregulatory Lectin, Galectin-1, in Precursor B Cell Acute Lymphoblastic Leukemias (ALLs) with MLL Rearrangements

Hodgkin’s Lymphoma Reed Sternberg Cells over Express the T-Cell Inhibitory Carbohydrate-Binding Lectin, Galectin 1: Role of AP-1 and Likely Mechanism of Tumor Immune Escape.

Email alerts

ASH Publications

American Society of Hematology

CXCR4 Upregulation Is a Biomarker Of Sensitivity To Targeted Inhibition Of B-Cell Receptor Signaling In Diffuse Large B-Cell Lymphoma

Galectin-1 Serum Levels Reflect Tumor Burden and Adverse Clinical Features in Hodgkin Lymphoma

Expression and Targeted Inhibition of the Immunoregulatory Carbohydrate-Binding Lectin, Galectin 1, in EBV-Driven Post-Transplant Lymphoproliferative Disorders.

Selective Expression of the Immunoregulatory Lectin, Galectin-1, in Precursor B Cell Acute Lymphoblastic Leukemias (ALLs) with MLL Rearrangements

Hodgkin’s Lymphoma Reed Sternberg Cells over Express the T-Cell Inhibitory Carbohydrate-Binding Lectin, Galectin 1: Role of AP-1 and Likely Mechanism of Tumor Immune Escape.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only